|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating activities | ||
| Net income | ||
| Adjustments to reconcile net income to net cash provided by/(used in) operating activities: | ||
| Depreciation and amortization | ||
| Impairment of intangible assets | ||
| Noncash lease expense | ||
| Stock-based compensation | ||
| Deferred income tax expense (benefit) | ||
| Charitable Contribution | ||
| Change in fair value of contingent consideration | ||
| Other investment gains | ||
| Net (gains) losses within CIPs | ||
| Net (purchases) proceeds within CIPs | ||
| (Earnings) losses from equity method investees | ||
| Distributions of earnings from equity method investees | ||
| Other adjustments | ||
| Accounts receivable | ||
| Investments, trading | ||
| Other assets | ||
| Accrued compensation and benefits | ||
| Accounts payable and accrued liabilities | ||
| Other liabilities | ||
| Net cash provided by/(used in) operating activities | ||
| Investing activities | ||
| Purchases of investments | ||
| Proceeds from sales and maturities of investments | ||
| Distributions of capital from equity method investees | ||
| Net consolidations (deconsolidations) of sponsored investment funds | ||
| Acquisitions, net of cash acquired | ||
| Purchases of property and equipment | ||
| Net cash provided by/(used in) investing activities | ||
| Financing activities | ||
| Repayments of long-term borrowings | ||
| Proceeds from long-term borrowings | ||
| Dividends/Subco distributions paid | ||
| Cash dividends paid | ||
| Proceeds from stock options exercised | ||
| Shares/Subco Units repurchased | ||
| Repurchases of common stock | ||
| Net proceeds from (repayments of) borrowings by CIPs | ||
| Net subscriptions received/(redemptions/distributions paid) from noncontrolling interest holders | ||
| Other financing activities | ||
| Net cash provided by/(used in) financing activities | ||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||
| Net increase/(decrease) in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash, beginning of year | ||
| Cash, cash equivalents and restricted cash, end of year | ||
| Supplemental disclosure of cash flow information: | ||
| Interest | ||
| Income taxes (net of refunds) | ||
| Supplemental schedule of noncash investing and financing transactions: | ||
| Issuance of common shares related to employee stock transactions | ||
| Issuance of common shares in connection with the GIP Transaction | ||
| Issuance of Subco Units/common shares in connection with acquisitions | ||
| Cancellation of treasury stock, common in connection with the GIP Transaction | ||
| Increase/(decrease) in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds | ||
| Established contingent consideration liabilities in connection with acquisitions |
Loading...
